ICD-10 Code C83.70 | Burkitt lymphoma, unspecified site Symptoms, Diagnosis, Billing

Burkitt lymphoma, unspecified site, is a highly aggressive form of non-Hodgkin lymphoma characterized by rapid cell proliferation. It is associated with genetic mutations, particularly involving the MYC oncogene. Accurate coding with ICD-10 Code C83.70 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this serious condition.

What is ICD-10 Code C83.70 for Burkitt lymphoma, unspecified site?

ICD-10 Code C83.70 represents Burkitt lymphoma, unspecified site, a type of non-Hodgkin lymphoma that can arise in various anatomical locations. This code is used when the specific site of the lymphoma is not documented. It is crucial for clinical documentation and billing to ensure appropriate treatment and resource allocation.

ICD-10 Code C83.70 – Clinical Definition and Explanation of Burkitt lymphoma, unspecified site

Burkitt lymphoma, unspecified site, is a highly aggressive B-cell lymphoma that often presents with rapidly enlarging tumors. It requires prompt medical intervention due to its aggressive nature and potential for widespread dissemination. The condition is primarily caused by chromosomal translocations involving the MYC gene, leading to uncontrolled cell growth.

Key Clinical Features:

• Rapidly growing lymphadenopathy, often in the abdomen or jaw.
• Potential involvement of the central nervous system.
• Commonly associated with immunocompromised states, such as HIV.
• High proliferation index, often indicated by elevated Ki-67 levels.

ICD-10 Code C83.70 for Burkitt lymphoma, unspecified site – SOAP Notes & Clinical Use

ICD-10 Code C83.70 is utilized in SOAP notes to document the presence of Burkitt lymphoma, unspecified site. It aids in capturing patient symptoms, assessments, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.

What Does ICD-10 Code C83.70 for Burkitt lymphoma, unspecified site Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C83.70 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Burkitt lymphoma, unspecified site. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C83.70 – Burkitt lymphoma, unspecified site

Burkitt lymphoma, unspecified site, necessitates urgent medical intervention, often requiring hospitalization for intensive chemotherapy. Treatment protocols may vary based on the patient's overall health and disease stage.

Antibiotic Therapy:

• Not applicable as Burkitt lymphoma is not an infectious disease.

Supportive Care:

• Management of tumor lysis syndrome with hydration and electrolyte monitoring.
• Pain management and palliative care as needed.
• Nutritional support to address weight loss and cachexia.

Infection Control:

• Implement standard precautions to prevent infections in immunocompromised patients.
• Monitor for signs of infection and initiate prophylactic antibiotics as indicated.

How to Document Symptoms of Burkitt lymphoma, unspecified site (ICD-10 C83.70) in SOAP Notes

Subjective:

• Patient reports rapid swelling in the abdomen and jaw.
• Complaints of night sweats and unexplained weight loss.
• History of fatigue and decreased appetite over the past month.

Objective:

• Physical examination reveals significant lymphadenopathy.
• Abdominal ultrasound shows enlarged spleen and liver.
• Laboratory tests indicate elevated lactate dehydrogenase (LDH) levels.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Burkitt lymphoma, unspecified site (ICD-10 Code C83.70)

Assessment:

• Diagnosis: Burkitt lymphoma, unspecified site, aggressive form.
• ICD-10 Code: C83.70.
• Contributing factors: Immunocompromised state due to underlying conditions.

Plan:

• Initiate chemotherapy regimen as per oncology guidelines.
• Provide education on potential side effects and symptom management.
• Schedule follow-up appointments for monitoring treatment response.

Treatment & Plan Section for ICD-10 Code C83.70 – Burkitt lymphoma, unspecified site

• First-line pharmacologic treatment includes intensive chemotherapy regimens such as R-CHOP or CODOX-M.
• Non-pharmacologic strategies include nutritional support and psychosocial counseling.
• Monitoring includes regular imaging studies and laboratory tests to assess treatment response.
• Follow-up practices involve close surveillance for recurrence and management of late effects.

Using ICD-10 Code C83.70 for Burkitt lymphoma, unspecified site in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical documentation of the condition.
• Ensure that subjective and objective findings are clearly documented in SOAP notes.
• Align treatment plans with clinical guidelines to support justified billing.
• Use CPT codes that correspond to the services provided for Burkitt lymphoma management.

Related ICD-10 Codes Often Used with Burkitt lymphoma, unspecified site

• C83.71 – Burkitt lymphoma, lymph node involvement
• C83.72 – Burkitt lymphoma, extranodal involvement

ICD-10 Code C83.70 in Medical Billing and Insurance for Burkitt lymphoma, unspecified site

ICD-10 Code C83.70 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use the code in conjunction with detailed notes on patient history and presenting symptoms.
• Ensure compliance with payer guidelines for coding and billing practices.

Common CPT Pairings: